That matters because trial participants are screened and monitored differently from people using medicines in routine care
doi: 10.1007/s00125-017-4289-0 26 CorkeyBE
GLP-1 has a short half-life of ~ 23 min due to rapid inactivation by the enzyme dipeptidyl peptidase (DPP)-4
GLP-1 Therapy with Oversight : We offer GLP-1 medications when clinically appropriate, with proper monitoring and provider-direct communication to ensure safety and results
BPC-157 for athletes and injury treatment: Science, safety, and legal concerns Maryke Louw Feb 17, 2025 5 min read Updated: Oct 3, 2025 BPC-157 is often marketed as a game-changing peptide for muscle repair, injury recovery, and athletic performance
Cevette MJ, Barrs DM, Patel A, et al